microscope software zen 3.1 (blue edition) (Carl Zeiss)
Carl Zeiss is a verified supplier 
Carl Zeiss manufactures this product 
90
Structured Review
Carl Zeiss
microscope software zen 3.1 (blue edition)
Microscope Software Zen 3.1 (Blue Edition), supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zen+3%2E1+blue+edition+software/software+zen/10__1091_slash_mbc__e25___02___0079-135-7-13
Average 90 stars, based on 1 article reviews
Microscope Software Zen 3.1 (Blue Edition), supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zen+3%2E1+blue+edition+software/software+zen/10__1091_slash_mbc__e25___02___0079-135-7-13
Average 90 stars, based on 1 article reviews
microscope software zen 3.1 (blue edition) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro Article Snippet: After capturing the images, the diameter covered by the 3D spheroids was measured using the Article Title: Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis. Article Snippet: Then, the Article Title: Mutations in hnRNP A1 drive neurodegeneration and alternative RNA splicing of neuronal gene targets. Article Snippet: RNA binding protein dysfunction is a pathogenic feature of multiple neurological diseases, including multiple sclerosis (MS).. Neurodegeneration (the loss of, or damage to neurons and axons) is the primary driver of disease progression in MS. Herein, we utilized a novel, neuron-specific model of neurodegeneration by transducing primary mouse neurons with mutant forms of the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) identified from MS patients, including one within the M9-nuclear localization sequence of hnRNP A1 (A1(P275S)) and a second in the prion-like domain of hnRNP A1 (A1(F263S)) to test the hypothesis that neuronal hnRNP A1 dysfunction drives neurodegeneration in MS.. Examination of hnRNP A1 localization in neurons revealed an increase in nucleocytoplasmic mislocalization in neurons transduced with A1(P275S), but not A1(F263S). Article Title: Comprehensive studies on the biological activities of human metastatic (MDA-MB-231) and non-metastatic (MCF-7) breast cancer cell lines, directly or combinedly treated using non-thermal plasma-based approaches. Article Snippet: Article Title: Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids <i>in vitro</i> Article Snippet: After capturing the images, the diameter covered by the 3D spheroids was measured 355 using the Article Title: Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids <i>in vitro</i> Article Snippet: Quantifying metastatic parameters in GBM spheroids following TMZ treatment. (A-B) 174 Diameter increase (μm) covered by U251MG WTE (A) and TLS Polκ KO cells (B) 3D tumor spheroids after 175 treatments with TMZ and respective controls for 0-, 24-, and 48 h. The diameter (μm) of migration of the 3D 176 tumor spheroids to the ECM after 0-, 24-, and 48 h were converted into % to the increase in diameter obtained at 177 0 h. ( Article Title: UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis. Article Snippet: Images were acquired using a Migration:Article Title: Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro Article Snippet: After capturing the images, the diameter covered by the 3D spheroids was measured using the Article Title: Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis. Article Snippet: Then, the Article Title: Mutations in hnRNP A1 drive neurodegeneration and alternative RNA splicing of neuronal gene targets. Article Snippet: RNA binding protein dysfunction is a pathogenic feature of multiple neurological diseases, including multiple sclerosis (MS).. Neurodegeneration (the loss of, or damage to neurons and axons) is the primary driver of disease progression in MS. Herein, we utilized a novel, neuron-specific model of neurodegeneration by transducing primary mouse neurons with mutant forms of the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) identified from MS patients, including one within the M9-nuclear localization sequence of hnRNP A1 (A1(P275S)) and a second in the prion-like domain of hnRNP A1 (A1(F263S)) to test the hypothesis that neuronal hnRNP A1 dysfunction drives neurodegeneration in MS.. Examination of hnRNP A1 localization in neurons revealed an increase in nucleocytoplasmic mislocalization in neurons transduced with A1(P275S), but not A1(F263S). Article Title: Comprehensive studies on the biological activities of human metastatic (MDA-MB-231) and non-metastatic (MCF-7) breast cancer cell lines, directly or combinedly treated using non-thermal plasma-based approaches. Article Snippet: Article Title: Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids <i>in vitro</i> Article Snippet: After capturing the images, the diameter covered by the 3D spheroids was measured 355 using the Article Title: Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids <i>in vitro</i> Article Snippet: Quantifying metastatic parameters in GBM spheroids following TMZ treatment. (A-B) 174 Diameter increase (μm) covered by U251MG WTE (A) and TLS Polκ KO cells (B) 3D tumor spheroids after 175 treatments with TMZ and respective controls for 0-, 24-, and 48 h. The diameter (μm) of migration of the 3D 176 tumor spheroids to the ECM after 0-, 24-, and 48 h were converted into % to the increase in diameter obtained at 177 0 h. ( Article Title: UBC9-Mediated SUMO Pathway Drives Prohibitin-1 Nuclear Accumulation and PITX1 Repression in Primary Osteoarthritis. Article Snippet: Images were acquired using a |